510(k) Report

510(k) · Cleared

Cleared

FUSION Vascular Graft

K153523510(k) TraditionalCleared Feb 16, 201669-day reviewClass II21 CFR 870.3450

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Maquet Cardiovascular, LLC · DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Cleared on Feb 16, 2016 as substantially equivalent to K131778 (Maquet Cardiovascular, LLC, 2013) and 1 other predicate after a 69-day review. Its family tree reaches back 5 generations to 1979.

Decided
Feb 16, 2016
Review
69 days
Class
Class II
Product code
DSY
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K791810 (1979). 15 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK791810 Vascular Graft Prost. of Expanded PtfeImpra, Inc. · 1979
  2. 4 generations backK955460 Meadox Medicals, Inc., Expanded & Externally Supported Expanded Ptfe…Meadox Medicals, Div. Boston Scientific Corp. · 1996
  3. 3 generations backK962433 Meadox Exxcel Eptfe Vascular GraftMeadox Medicals, Div. Boston Scientific Corp. · 1997
  4. 2 generations backK052964 Exxcel and Exxcel Soft Eptfe Vascular Grafts, Microvel Double Velour…Boston Scientific Corp · 2006 · Recalled
  5. 1 generation backK131778 Fusion Vascular Graft and Fusion Bioline Vascular GraftMaquet Cardiovascular, LLC · 2013 · Recalled
  6. This deviceK153523 FUSION Vascular GraftMaquet Cardiovascular, LLC · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K791810Vascular Graft Prost. of Expanded PtfeImpra, Inc.1979—
−4K955460Meadox Medicals, Inc., Expanded & Externally Supported Expanded Ptfe Vascular…Meadox Medicals, Div. Boston Scientific Corp.1996—
−3K962433Meadox Exxcel Eptfe Vascular GraftMeadox Medicals, Div. Boston Scientific Corp.1997—
−2K052964Exxcel and Exxcel Soft Eptfe Vascular Grafts, Microvel Double Velour Knitted…Boston Scientific Corp20063
−1K131778Fusion Vascular Graft and Fusion Bioline Vascular GraftMaquet Cardiovascular, LLC20131
0 (this device)K153523FUSION Vascular GraftMaquet Cardiovascular, LLC2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198120
198220
198310
198410
198810
199410
199710
201210
FIG. 1 — Lineage of K153523, 1979–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSY device

  1. #1 K252445 Fusion Bioline Vascular Graftscore 12.4 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K131778Fusion Vascular Graft and Fusion Bioline Vascular Graft
Summary page 4
…Drug and Cosmetic Act, the device classification is Class II, Product code DSY. Predicate Devices: K131778 FUSION Vascular Grafts (SE: 14 November 2013) K962433 EXXCEL ePTFE Va…
Maquet Cardiovascular, LLC20131
*K962433Meadox Exxcel Eptfe Vascular Graft
Summary page 4
…Product code DSY. Predicate Devices: K131778 FUSION Vascular Grafts (SE: 14 November 2013) K962433 EXXCEL ePTFE Vascular Graft (SE: 1 April 1997) Device Description: FUSION Vascular Graft…
Meadox Medicals, Div. Boston Scientific Corp.1997—

Also cleared against K131778: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 37 years and passes through 4 companies; a new generation was cleared every 7.9 years on median.
  • 2 of the 15 ancestors have a recall of any class.
  • 1 other device also cites its predicate K131778.

How does its category compare?

All DSY devices

DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · DSY

2in 2025

2007: 12008: 12009: 52010: 42011: 12012: 42013: 52014: 22015: 12016: 12017: 32018: 12019: 12020: 12021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 5 (2009) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSY

160in 2024

2009: 73 days median2010: 55 days median2012: 30 days median2013: 69 days median2017: 269 days median2024: 160 days median
2007high 269 (2017) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSY

1in 2025

2009: 22010: 52013: 12016: 22025: 12026 (partial year): 1
2007high 5 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSY

151in 2025

2007: 1202008: 1642009: 1932010: 1872011: 1652012: 1772013: 2072014: 3522015: 4602016: 2172017: 1932018: 2002019: 2322020: 1692021: 1682022: 1552023: 1492024: 1532025: 151
2007high 460 (2015) · low 120 (2007)2025

MAUDE reports naming product code DSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0120
20081—0164
20095732193
20104555187
20111—0165
20124300177
20135691207
20142—0352
20151—0460
20161—2217
201732690193
20181—0200
20191—0232
20201—0169
20212—0168
20222—0155
20232—0149
202451600153
20252—1151
20261—1—

What is it indicated for?

FUSION Vascular Grafts are designed to repair or replace peripheral arteries and to provide vascular access.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K153523: FUSION Vascular Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K153523

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026